Merck & Company Inc

Healthcare · Drug Manufacturers - General

150.90$ +0.9% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

Merck & Company Inc (MRK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 136,866 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MRK
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	24,293	25,736	31,853	35,635	39,910	44,021	47,561	40,588	42,573	44,846	44,570	48,351	47,196	112,314	105,781	105,128	106,132	105,645	98,167	101,677	95,377	87,872	82,637	84,397	91,588	105,694	109,160	106,675	117,106	136,866
Current Assets	7,727	8,213	10,229	11,259	13,353	12,962	14,386	11,527	13,475	21,049	15,230	15,045	19,113	28,432	29,064	33,181	34,857	35,685	32,605	29,751	30,614	24,766	25,875	27,483	27,764	30,266	35,722	32,168	38,782	43,516
Cash	1,352	1,125	2,606	2,022	2,537	2,144	2,243	1,201	2,879	9,585	5,915	5,336	4,368	9,311	10,900	13,531	13,451	15,621	7,441	8,524	6,515	6,092	7,965	9,676	8,050	8,096	12,694	6,841	13,242	14,565
Cash & Short-Term Investments	1,352	1,125	2,606	3,202	4,255	3,287	4,971	4,173	7,090	15,638	8,713	8,231	5,486	9,604	12,201	14,972	16,141	17,486	15,719	13,427	14,341	8,498	8,864	10,450	8,050	8,096	13,192	7,093	13,689	14,565
Receivables	2,656	2,877	3,374	4,089	5,018	5,215	5,423	4,024	3,628	2,927	3,315	3,636	2,908	6,603	7,344	8,261	7,672	7,184	6,626	6,484	7,018	6,873	7,071	6,778	6,803	9,230	9,450	10,349	10,278	12,679
Inventory	2,149	2,145	2,624	2,847	3,022	3,579	2,964	2,555	1,899	1,658	1,769	1,881	2,091	8,048	5,868	6,254	6,535	6,226	5,571	4,700	4,866	5,096	5,440	5,978	5,554	5,953	5,911	6,358	6,109	6,658
Property, Plant & Equipment	–	–	–	–	11,482	13,103	14,196	14,169	14,714	14,398	13,194	12,346	12,000	18,274	17,082	16,297	16,030	14,973	13,136	12,507	12,026	12,439	13,291	15,053	17,986	19,279	21,422	24,488	25,149	26,823
Goodwill	–	–	–	–	3,800	4,100	4,127	1,085	209	1,086	1,432	1,455	1,439	12,038	12,378	12,155	12,134	12,301	12,992	17,723	18,162	18,284	18,253	19,425	18,882	21,264	21,204	21,197	21,668	21,579
Intangible Assets	6,737	6,781	8,287	7,584	7,374	7,491	7,241	1,949	1,765	519	944	713	525	47,757	39,456	34,302	29,083	23,801	20,386	22,602	17,305	14,183	13,104	14,196	14,101	22,933	20,269	18,011	16,370	26,681
Total Liabilities	10,012	11,975	15,347	18,933	20,057	23,134	24,432	21,096	22,878	24,461	24,604	27,759	26,029	50,829	48,976	48,185	50,669	53,319	49,376	56,910	55,069	53,303	55,755	58,396	66,184	67,437	63,102	69,040	70,734	84,204
Current Liabilities	4,829	5,569	6,069	8,759	9,710	11,544	12,375	9,570	11,744	13,242	12,723	12,258	14,319	15,641	15,641	16,245	18,348	17,868	18,397	19,201	17,204	18,614	22,206	22,220	27,327	23,872	24,239	25,694	28,420	28,327
Short-Term Debt	606	903	624	2,859	3,319	4,067	3,670	1,700	2,181	2,972	1,285	1,824	2,297	1,379	2,400	1,990	4,315	4,521	2,704	2,583	568	3,057	5,308	3,610	6,722	2,716	2,227	1,657	2,931	2,883
Accounts Payable	2,938	3,269	3,682	4,159	4,361	5,108	2,413	735	421	471	497	625	618	2,244	2,308	2,023	1,753	2,274	2,625	2,533	2,807	3,102	3,318	3,738	4,327	4,609	4,264	3,922	4,079	4,404
Long-Term Debt	–	–	–	–	3,601	4,799	4,879	5,096	4,692	5,126	5,551	3,916	3,943	16,075	15,482	15,525	16,254	20,539	18,699	23,929	24,274	21,353	19,806	22,736	25,360	30,690	28,745	33,683	34,462	46,750
Shareholders' Equity	11,971	12,595	12,802	13,242	14,832	16,050	18,201	15,576	17,288	17,978	17,560	18,185	18,758	59,058	54,376	54,517	53,020	49,765	48,647	44,676	40,088	34,336	26,701	25,907	25,317	38,184	45,991	37,581	46,313	52,606
Retained Earnings	14,818	17,292	20,187	23,448	27,364	31,490	35,435	34,142	36,626	37,980	39,095	39,141	43,699	41,405	37,536	38,990	39,985	39,257	46,021	45,348	44,133	41,350	42,579	46,602	47,362	53,696	61,081	53,895	63,069	73,075
Shares Outstanding	2,488	2,467	2,441	2,405	2,353	2,322	2,277	2,253	2,226	2,200	2,188	2,193	2,143	2,273	3,120	3,094	3,076	2,996	2,928	2,841	2,787	2,748	2,679	2,580	2,541	2,538	2,542	2,547	2,541	2,507

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings